Myelin Repair Foundation appointed Dr. Alfred Sandrock, Chief Medical Officer from Biogen Idec to our Clinical Advisory Board

Stuart SchlossmanMisc. MS Related
 
We are very pleased to announce that this week the Myelin Repair Foundation appointed Dr. Alfred Sandrock, Chief Medical Officer from Biogen Idec to our Clinical Advisory Board (CAB). As the quintessential expert on developing drugs for multiple sclerosis, Dr. Sandrock joins MRF’s mission to accelerate the drug discovery process for a multiple sclerosis cure.
The Myelin Repair Foundation established the CAB to accelerate the clinical development phase of our research plan, in order to achieve our first clinical trial for myelin repair in 2014. Dr. Sandrock will serve alongside fellow board members Dr. Peter Calabresi, Dr. Roland Martin, Dr. Daniel Reich, Dr. Scott Zamvil and CAB chair Dr. Henry McFarland.
You may read the full press release here, or learn more about MRF’s recent research breakthroughs by visiting our website at www.myelinrepair.org.
Best regards,
Myelin Repair Foundation Staff


..
Comments are appreciated. Note that All comments are moderated 
 If not yet receiving our weekly e-Newsletter – Click here to: REGISTER –
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

…………………………
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews